212 related articles for article (PubMed ID: 2416619)
1. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
Grill V; Rundfeldt M
Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
[TBL] [Abstract][Full Text] [Related]
2. B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia.
Grill V; Westberg M; Ostenson CG
J Clin Invest; 1987 Sep; 80(3):664-9. PubMed ID: 2442195
[TBL] [Abstract][Full Text] [Related]
3. Nutrient-induced priming of insulin and glucagon secretion. Effects of alpha-ketoisocaproic acid.
Grill V
Endocrinology; 1982 Mar; 110(3):1013-7. PubMed ID: 6173206
[TBL] [Abstract][Full Text] [Related]
4. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
Leahy JL; Bonner-Weir S; Weir GC
Diabetes; 1985 Jul; 34(7):660-6. PubMed ID: 2408948
[TBL] [Abstract][Full Text] [Related]
5. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
Grill V; Efendić S
Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
[TBL] [Abstract][Full Text] [Related]
6. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.
Sako Y; Grill VE
Endocrinology; 1990 Oct; 127(4):1580-9. PubMed ID: 1698143
[TBL] [Abstract][Full Text] [Related]
7. Multiple abnormalities in insulin responses to nonglucose nutrients in neonatally streptozotocin diabetic rats.
Grill V; Sako Y; Ostenson CG; Jalkanen P
Endocrinology; 1991 Apr; 128(4):2195-203. PubMed ID: 1706269
[TBL] [Abstract][Full Text] [Related]
8. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
Grill V; Westberg M
Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
[TBL] [Abstract][Full Text] [Related]
9. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats.
Ostenson CG; Efendic S; Grill V
Pancreas; 1990 May; 5(3):347-53. PubMed ID: 1971441
[TBL] [Abstract][Full Text] [Related]
10. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas.
Giroix MH; Portha B; Kergoat M; Bailbe D; Picon L
Diabetes; 1983 May; 32(5):445-51. PubMed ID: 6341128
[TBL] [Abstract][Full Text] [Related]
11. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
12. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
Sako Y; Grill VE
Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
[TBL] [Abstract][Full Text] [Related]
13. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
14. Preserved initiatory and potentiatory effect of alpha-ketoisocaproate on insulin release in islets of glucose intolerant rats.
Guenifi A; Abdel-Halim SM; Efendic S; Ostenson CG
Diabetologia; 1998 Nov; 41(11):1368-73. PubMed ID: 9833946
[TBL] [Abstract][Full Text] [Related]
15. Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats.
Okabayashi Y; Otsuki M; Ohki A; Tani S; Baba S
Diabetes; 1989 Aug; 38(8):1042-7. PubMed ID: 2526762
[TBL] [Abstract][Full Text] [Related]
16. Impaired insulin biosynthetic capacity in a rat model for non-insulin-dependent diabetes. Studies with dexamethasone.
Giddings SJ; Orland MJ; Weir GC; Bonner-Weir S; Permutt MA
Diabetes; 1985 Mar; 34(3):235-40. PubMed ID: 3882490
[TBL] [Abstract][Full Text] [Related]
17. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.
Leahy JL; Bonner-Weir S; Weir GC
Diabetes; 1984 Jul; 33(7):667-73. PubMed ID: 6203798
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Pederson RA; Ramanadham S; Buchan AM; McNeill JH
Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
[TBL] [Abstract][Full Text] [Related]
19. Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.
Chen C; Thorens B; Bonner-Weir S; Weir GC; Leahy JL
Diabetes; 1992 Oct; 41(10):1320-7. PubMed ID: 1397706
[TBL] [Abstract][Full Text] [Related]
20. Inducement by fat feeding of basal hyperglycemia in rats with abnormal beta-cell function. Model for study of etiology and pathogenesis of NIDDM.
Pascoe WS; Storlien LH
Diabetes; 1990 Feb; 39(2):226-33. PubMed ID: 2146180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
